Role of Surgery Following Induction Therapy for Stage III Non-Small Cell Lung Cancer

Surgical Oncology Clinics of North America

Volumn 20, Issue 4, 2011, Pages 721-732

  Daly, Benedict D T ^a,b   Cerfolio, Robert J ^c,d   Krasna, Mark J ^e  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama Birmingham ^*

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e MERIDIAN HEALTH SYSTEM   (United States)

Author keywords

Neoadjuvant induction therapy; Non small cell lung cancer; Radiotherapy; Tumor resection

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; IFOSFAMIDE; MITOMYCIN; PACLITAXEL; UFT; VINBLASTINE; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; DOSIMETRY; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG RESECTION; OVERALL SURVIVAL; REVIEW; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; REMISSION INDUCTION;

EID: 80053903888     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2011.07.006     Document Type: Review

References (52)

1. Martini N., Flehinger B.J. The role of surgery in N2 lung cancer. Surg Clin North Am 1987, 67:1037-1049.
2. Pearson F.G., DeLarue N.C., Ilves R., et al. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable lung cancer. J Thorac Cardiovasc Surg 1982, 83:1-11.
3. Jaklitsch M.T., Strauss G.M., Sugarbaker D.J. Neoadjuvant and adjuvant therapy in the management of locally advanced non-small cell lung cancer. World J Surg 1993, 17:729-734.
4. Martini N., Kris M., Flehinger B.J., et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993, 55:1365-1373.
5. Burkes R.L., Ginsberg R.J., Sheperd F.A., et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for Stage III unresectable non-small cell lung cancer; results of the Toronto phase II trial. J Clin Oncol 1992, 10:580-586.
6. Ginsberg R.J. Neoadjuvant (induction) treatment for non-small cell lung cancer. Lung Cancer 1995, 12:S33-S40.
7. Roth J.A., Fosella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable Stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994, 86:673-680.
8. Rosell R., Gomez-Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994, 330:153-158.
9. Sugarbaker D.J., Herndon J., Kohman L.J., et al. Cancer and Leukemia Group B Thoracic Surgery Group. Results of cancer and leukemia group B protocol 8935A mutiinstitutional phase II trimodality trial for Stage IIIa (N2) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1995, 109:473-485.
10. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for Stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995, 13:1880-1892.
11. Rusch V.W., Giroux D.J., Kraut M.J., et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup trial 0160). J Thorac Cardiovasc Surg 2001, 121:472-483.
12. Rusch V.W., Giroux D.J., Kraut M.J., et al. Induction chemoradiation and surgical resection for superior sulcus non-small cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup trial 0160). J Clin Oncol 2007, 25:313-318.
13. Albain K.S., Scott C.B., Rusch V.R., et al. Phase III study of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer: initial results from intergroup trial 0139 (RTOG 93-09). Proc Am Soc Clin Oncol 2003, 22:621. [abstract].
14. Albain K.S., Swann R.S., Rusch V.W., et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomized controlled trial. Lancet 2009, 374:379-386.
15. Sonett J.R., Krasna M.J., Suntharalingam M., et al. Safe pulmonary resection after chemotherapy and high-dose thoracic radiation. Ann Thorac Surg 1999, 68:316-320.
16. Vora S.A., Daly B.D., Blaszkowsky L., et al. High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. Cancer 2000, 89:1946-1952.
17. Sonett J.R., Suntharalingam M., Edelman M.J., et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 2004, 78:1200-1206.
18. Cerfolio R.J., Bryant A.S., Spencer S.A., et al. Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg 2005, 80:1224-1230.
19. Kwong K.F., Edelman M.J., Suntharalingam M., et al. High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival. J Thorac Cardiovasc Surg 2005, 129:1250-1255.
20. Daly B.D., Fernando H.C., Ketchedjian A., et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg 2006, 82:227-231.
21. Edelman M.J., Suntharalingam M., Burrows W., et al. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer. Ann Thorac Surg 2008, 86:903-911.
22. Krasna M.J., Gamliel Z., Burrows W.M., et al. Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation. Ann Thorac Surg 2010, 89:200-206.
23. Daly B.D., Ebright M.I., Walkey A.J., et al. Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer. J Thorac Cardiovasc Surg 2011, 141(6):1392-1397.
24. Weiden P.L., Piantadosi S. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 1991, 83:266-273.
25. Yashar J., Weitberg A.B., Glicksman A.S., et al. Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung. Ann Thorac Surg 1992, 53:445-448.
26. Mathisen D.J., Wain J.C., Wright C., et al. Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1996, 111:123-133.
27. Eberhardt W., Wilke H., Stamatis G., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 1998, 16:622-634.
28. Rice T.W., Adelstein D.J., Ciezki J.P., et al. Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer. Ann Thorac Surg 1998, 66:1909-1914.
29. Stamatis G., Eberhardt W., Stuben G., et al. Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results. Ann Thorac Surg 1999, 68:1144-1149.
30. Junker K., Langner K., Klinke F., et al. Grading of tumor regression in non-small cell lung cancer: morphology and prognosis. Chest 2001, 120:1584-1591.
31. Grunenwald D.H., Andre F., Le Pechoux C., et al. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg 2001, 122:796-802.
32. Cyjon A., Nili M., Fink G., et al. Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation. Ann Thorac Surg 2002, 74:342-347.
33. Granetzny A., Striehn E., Bosse U., et al. A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer. Ann Thorac Surg 2003, 75:1107-1112.
34. Betticher D.C., Schmitz S.H., Totsch M., et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003, 21(9):1752-1759.
35. Galetta D., Cesario A., Margaritora S., et al. Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach. Ann Thorac Surg 2003, 76:1802-1809.
36. Ichinose Y., Fukuyama Y., Asoh H., et al. Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer. Ann Thorac Surg 2003, 76:1810-1815.
37. DeCamp M.M., Rice T.W., Adelstein D.J., et al. Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer. J Thorac Cardiovasc Surg 2003, 126:17-27.
38. Thomas M., Macha H.N., Ukena D., et al. Cisplatin/etoposide (PE) followed by twice-daily chemoradiation (hfRT/CT) versus PE alone before surgery in stage III non-small cell lung cancer (NSCLC): a randomized phase III trial of the German Lung Cancer Cooperative Group (GLCCG). J Clin Oncol 2004, 22:14S.
39. Machtay M., Lee J.H., Stevenson J.P., et al. Two commonly used neoadjuvant chemotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. J Thorac Cardiovasc Surg 2004, 127:108-113.
40. Steger V., Walles T., Kosan B., et al. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival. Ann Thorac Surg 2009, 87:1676-1683.
41. Caglar H.B., Baldini E.H., Othus M., et al. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer 2009, 115:4156-4166.
42. Strauss G.M., Herndon J.E., Sherman D.D., et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992, 10:1237-1244.
43. Bueno R., Richards W.C., Swanson S.J., et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000, 70:1826-1831.
44. Stefani A., Alifano M., Bobbio A., et al. Which patients should be operated on after induction chemotherapy for non-small cell lung cancer? Analysis of a 7-year experience in 175 patients. J Thorac Cardiovasc Surg 2010, 140:356-363.
45. Paul S., Mirza F., Port J.L., et al. Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of resection as independent predictors. J Thorac Cardiovasc Surg 2011, 141:48-55.
46. Adelstein D.J., Rice T.W., Rybicki L.A., et al. Long-term follow-up after chemoradiotherapy (CRT) in patients (pts) with stage III non-small cell lung cancer (NSCLC): is bulky mediastinal nodal disease of prognostic importance?. J Clin Oncol 2004, 22:14S. [abstract].
47. Okada M., Tsubota N., Yoshimura M., et al. Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations. Chest 2000, 118:123-128.
48. Doddoli C.D., Barlesi F., Trousse D., et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer; an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 2005, 130:416-425.
49. Allen A.M., Mentzer S.J., Yeap B.Y., et al. Pneumonectomy after chemoradiation: the Dana-Farber cancer Institute/Brigham and Women's Hospital Experience. Cancer 2008, 112:1106-1113.
50. Gudbjartsson T., Gyllstedt E., Pikwer A., et al. Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy. Ann Thorac Surg 2008, 86:376-382.
51. Weder W., Colland S., Eberhardt W.E., et al. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer. J Thorac Cardiovasc Surg 2010, 139:1424-1430.
52. Martin J., Ginsberg R.J., Abolhoda A., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 2001, 72:1149-1154.